Literature DB >> 27427843

Caring for Patients With Severe and Enduring Eating Disorders (SEED): Certification, Harm Reduction, Palliative Care, and the Question of Futility.

Patricia Westmoreland1, Phillip S Mehler.   

Abstract

Anorexia nervosa is a serious mental illness with a high mortality rate. The body image distortion inherent to this disorder and the impaired judgment and cognition due to malnutrition frequently result in patients refusing treatment. Treatment is most effective if patients are treated early in the course of their illness and undergo a full course of treatment. Involuntary treatment may therefore be both life-saving and critical to recovery. Between April 2012 and March 2016, 109 patients (5.2% of patients admitted to the Eating Recovery Center in Denver, CO) were certified, 39% of whom were transferred from the ACUTE Center for Eating Disorders at Denver Health Medical Center. Of these 109 certified patients, 31% successfully completed treatment, and 42% returned for a further episode of care; 24% of the certifications were terminated as involuntary treatment was not found to be helpful. Conclusions supported by these data are that patients with anorexia nervosa who are the most medically ill often require involuntary treatment. In addition, although many patients who are certified successfully complete treatment, involuntary treatment is not helpful approximately 25% of the time. Many of the patients for whom certification is ineffective are those who suffer from a lifetime of illness that is severe and enduring. Patients with severe and enduring eating disorders (SEED) typically undergo cyclical weight restoration and weight loss. Many of these patients question the value of serial treatments, especially when they have few (if any) illness-free intervals. Patients, families, and treating physicians often wish to explore other models of care, including harm reduction and palliative care. In addition, patients with SEED may also contemplate whether a compassionate death would be better than an ongoing lifetime of suffering. In this review, we outline arguments for and against the concept of futility in SEED, and explore whether (or when) patients are competent to make the decision to die.

Entities:  

Mesh:

Year:  2016        PMID: 27427843     DOI: 10.1097/PRA.0000000000000160

Source DB:  PubMed          Journal:  J Psychiatr Pract        ISSN: 1527-4160            Impact factor:   1.325


  8 in total

1.  Exploring the Healthcare Environment and Associations with Clinical Outcomes of People Living with HIV/AIDS.

Authors:  Mary Hawk; Robert W S Coulter; James E Egan; Mackey Reuel Friedman; Steven Meanley; Stuart Fisk; Courtney Watson; Suzanne Kinsky
Journal:  AIDS Patient Care STDS       Date:  2017-11-17       Impact factor: 5.078

2.  Terminal anorexia nervosa is a dangerous term: it cannot, and should not, be defined.

Authors:  Angela S Guarda; Annette Hanson; Philip Mehler; Patricia Westmoreland
Journal:  J Eat Disord       Date:  2022-06-07

3.  Embodiment as a Paradigm for Understanding and Treating SE-AN: Locating the Self in Culture.

Authors:  Connie Marguerite Musolino; Megan Warin; Peter Gilchrist
Journal:  Front Psychiatry       Date:  2020-06-12       Impact factor: 4.157

4.  A palliative care approach in psychiatry: clinical implications.

Authors:  Mattias Strand; Manne Sjöstrand; Anna Lindblad
Journal:  BMC Med Ethics       Date:  2020-04-19       Impact factor: 2.652

5.  Terminal anorexia nervosa: three cases and proposed clinical characteristics.

Authors:  Jennifer L Gaudiani; Alyssa Bogetz; Joel Yager
Journal:  J Eat Disord       Date:  2022-02-15

6.  Eating disorders and palliative care specialists require definitional consensus and clinical guidance regarding terminal anorexia nervosa: addressing concerns and moving forward.

Authors:  Joel Yager; Jennifer L Gaudiani; Jonathan Treem
Journal:  J Eat Disord       Date:  2022-09-06

7.  Creating a care pathway for patients with longstanding, complex eating disorders.

Authors:  Megan Reay; Joanna Holliday; John Stewart; Joanna Adams
Journal:  J Eat Disord       Date:  2022-08-29

Review 8.  Ketamine as a Novel Psychopharmacotherapy for Eating Disorders: Evidence and Future Directions.

Authors:  Anya Ragnhildstveit; Matthew Slayton; Laura Kate Jackson; Madeline Brendle; Sachin Ahuja; Willis Holle; Claire Moore; Kellie Sollars; Paul Seli; Reid Robison
Journal:  Brain Sci       Date:  2022-03-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.